PUBLIC CONTRACT · 2022
Vários Medicamentos
- Contract value
- €9,563.73
- Signed on
- 29 September 2022
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9489471PUBLISHED DESCRIPTION
61020322 - AQ Urgente Medicamentos
Parties involved
- Awardee
- MYLAN, LDA.; Abbott Medical Portugal; BIOGEN PORTUGAL, SOC FARMACÊUTICA, UNIPESSOAL; TECNIMEDE-SOCIEDADE TECNICO-MEDICINAL S.A.; Alfasigma Portugal, Lda
- Place of performance
- Portugal, Setúbal, Setúbal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- MYLAN, LDA. · Tax ID 502248793
- Awardee
- Abbott Medical Portugal · Tax ID 504180746
- Awardee
- BIOGEN PORTUGAL, SOC FARMACÊUTICA, UNIPESSOAL · Tax ID 506415740
- Awardee
- TECNIMEDE-SOCIEDADE TECNICO-MEDICINAL S.A. · Tax ID 500626413
- Awardee
- Alfasigma Portugal, Lda · Tax ID 502857722
Values and timeline
- Contract price
- €9,563.73
- Procedure base price
- €9,563.73
- Total effective price
- Not reported on Portal BASE
- Publication date
- 10 October 2022
- Award date
- 29 September 2022
- Signing date
- 29 September 2022
- Performance period
- 12 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2021/61 - Medicamentos diversos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6093271
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.